IP Library Granted Patent US 7,968,280
Granted Patent B2
US 7,968,280 · App. 11/292,295 · Granted Jun 28, 2011

Methods for the detection and/or quantification of gram positive bacterial contaminants

Assignee: Charles River Laboratories, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,280
App. No.
11/292,295
Granted
Jun 28, 2011
Kind
B2
Abstract

The invention provides methods and compositions for the detection and/or quantification of a Gram positive bacterial contaminant in a sample. In particular, the invention provides hemocyte-based preparations, methods of making such hemocyte-based preparations, and methods of using such hemocyte-based preparations for the detection and/or quantification of the Gram positive bacterial contaminant.

Claims (12)

1. A method of producing a preparation for detecting the presence and/or quantity of lipoteichoic acid in a sample, the method comprising the steps of:

(a) providing a crustacean hemocyte preparation, wherein the crustacean hemocytes in the preparation (i) have an outer membrane and (ii) contain lipoteichoic acid reactive material disposed therein;

(b) rendering the outer membrane of at least a portion of the crustacean hemocytes in the crustacean hemocyte preparation permeable to the lipoteichoic acid reactive material so that the lipoteichoic acid reactive material is released from the crustacean hemocytes;

(c) harvesting the lipoteichoic acid reactive material released from the crustacean hemocytes; and

(d) determining that the lipoteichoic acid reactive material harvested in step (c) is activatable by lipoteichoic acid such that prophenol oxidase is converted into phenol oxidase when the lipoteichoic acid reactive material is contacted with lipoteichoic acid.

2. The method of claim 1 , wherein in step (b), the outer membrane is rendered selectively permeable by exposure to a membrane permeabilizing agent.

3. The method of claim 2 , wherein the permeabilizing agent is an ionophore.

4. The method of claim 3 , wherein the ionophore is a calcium ionophore.

5. The method of claim 1 , wherein the crustacean is selected from the group consisting of Cancer borealis, Cancer irroratus, Carcinus maenas, Hemigrapsus sanguineus , and Limulus polyphemus.

6. The method of claim 1 , wherein the crustacean Cancer genus.

7. The method of claim 3 , wherein the ionophore is admixed with the crustacean hemocyte preparation to give a final concentration in the range from about 0.1 μM to about 100 μM.

8. The method of claim 7 , wherein the ionophore is admixed with the crustacean hemocyte preparation to give a final concentration in the range from about 1 μM to about 10 μM.

Assignments (5)
SECURITY AGREEMENT Recorded Nov 18, 2010
From: CHARLES RIVER LABORATORIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025388/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2006
From: JORDAN, FOSTER T.
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 017174/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2006
From: WAINWRIGHT, NORMAN R.
To: MARINE BIOLOGICAL LABORATORY
Reel/Frame 017174/0536 →
LICENSE Recorded Feb 15, 2006
From: MARINE BIOLOGICAL LABORATORY
To: NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Reel/Frame 017174/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2006
From: MARINE BIOLOGICAL LABORATORY
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 017174/0583 →
Continuity (2)
Provisional Application 60632785 · Dec 2, 2004
Related Publication 20060183181A1 · Aug 17, 2006